List of Excipients in API pirtobrutinib
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing pirtobrutinib
Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
---|---|---|---|---|---|
Eli Lilly and Company | JAYPIRCA | pirtobrutinib | 0002-6902 | CELLULOSE, MICROCRYSTALLINE | 2030-12-01 |
Eli Lilly and Company | JAYPIRCA | pirtobrutinib | 0002-6902 | CROSCARMELLOSE SODIUM | 2030-12-01 |
Eli Lilly and Company | JAYPIRCA | pirtobrutinib | 0002-6902 | FD&C BLUE NO. 2 ALUMINUM LAKE | 2030-12-01 |
Eli Lilly and Company | JAYPIRCA | pirtobrutinib | 0002-6902 | HYPROMELLOSE | 2030-12-01 |
>Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Detailed excipient profiles for pirtobrutinib
Excipient focus: CELLULOSE, MICROCRYSTALLINE
pirtobrutinib drug variants containing CELLULOSE, MICROCRYSTALLINE
Company | Ingredient | NDC |
---|---|---|
Eli Lilly and Company | pirtobrutinib | 0002-6902 |
>Company | >Ingredient | >NDC |
pirtobrutinib drug variants not containing CELLULOSE, MICROCRYSTALLINE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: CROSCARMELLOSE SODIUM
pirtobrutinib drug variants containing CROSCARMELLOSE SODIUM
Company | Ingredient | NDC |
---|---|---|
Eli Lilly and Company | pirtobrutinib | 0002-6902 |
>Company | >Ingredient | >NDC |
pirtobrutinib drug variants not containing CROSCARMELLOSE SODIUM
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: FD&C BLUE NO. 2 ALUMINUM LAKE
pirtobrutinib drug variants containing FD&C BLUE NO. 2 ALUMINUM LAKE
Company | Ingredient | NDC |
---|---|---|
Eli Lilly and Company | pirtobrutinib | 0002-6902 |
>Company | >Ingredient | >NDC |
pirtobrutinib drug variants not containing FD&C BLUE NO. 2 ALUMINUM LAKE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE
pirtobrutinib drug variants containing HYPROMELLOSE
Company | Ingredient | NDC |
---|---|---|
Eli Lilly and Company | pirtobrutinib | 0002-6902 |
>Company | >Ingredient | >NDC |
pirtobrutinib drug variants not containing HYPROMELLOSE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE ACETATE SUCCINATE 12070923
pirtobrutinib drug variants containing HYPROMELLOSE ACETATE SUCCINATE 12070923
Company | Ingredient | NDC |
---|---|---|
Eli Lilly and Company | pirtobrutinib | 0002-6902 |
>Company | >Ingredient | >NDC |
pirtobrutinib drug variants not containing HYPROMELLOSE ACETATE SUCCINATE 12070923
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: LACTOSE MONOHYDRATE
pirtobrutinib drug variants containing LACTOSE MONOHYDRATE
Company | Ingredient | NDC |
---|---|---|
Eli Lilly and Company | pirtobrutinib | 0002-6902 |
>Company | >Ingredient | >NDC |
pirtobrutinib drug variants not containing LACTOSE MONOHYDRATE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
pirtobrutinib drug variants containing MAGNESIUM STEARATE
Company | Ingredient | NDC |
---|---|---|
Eli Lilly and Company | pirtobrutinib | 0002-6902 |
>Company | >Ingredient | >NDC |
pirtobrutinib drug variants not containing MAGNESIUM STEARATE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: SILICON DIOXIDE
pirtobrutinib drug variants containing SILICON DIOXIDE
Company | Ingredient | NDC |
---|---|---|
Eli Lilly and Company | pirtobrutinib | 0002-6902 |
>Company | >Ingredient | >NDC |
pirtobrutinib drug variants not containing SILICON DIOXIDE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
pirtobrutinib drug variants containing TITANIUM DIOXIDE
Company | Ingredient | NDC |
---|---|---|
Eli Lilly and Company | pirtobrutinib | 0002-6902 |
>Company | >Ingredient | >NDC |
pirtobrutinib drug variants not containing TITANIUM DIOXIDE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: TRIACETIN
pirtobrutinib drug variants containing TRIACETIN
Company | Ingredient | NDC |
---|---|---|
Eli Lilly and Company | pirtobrutinib | 0002-6902 |
>Company | >Ingredient | >NDC |
pirtobrutinib drug variants not containing TRIACETIN
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.